We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q4 Earnings
Read MoreHide Full Article
Wall Street analysts expect GE HealthCare Technologies (GEHC - Free Report) to post quarterly earnings of $1.26 per share in its upcoming report, which indicates a year-over-year increase of 6.8%. Revenues are expected to be $5.33 billion, up 2.4% from the year-ago quarter.
The current level reflects a downward revision of 0.6% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
That said, let's delve into the average estimates of some GE HealthCare metrics that Wall Street analysts commonly model and monitor.
The consensus estimate for 'Revenues- Imaging' stands at $2.42 billion. The estimate suggests a change of -14.5% year over year.
According to the collective judgment of analysts, 'Revenues- Ultrasound' should come in at $1.41 billion. The estimate suggests a change of +49.4% year over year.
It is projected by analysts that the 'Revenues- Other' will reach $11.24 million. The estimate points to a change of -19.7% from the year-ago quarter.
The consensus among analysts is that 'Revenues- PDx' will reach $631.89 million. The estimate points to a change of +6.9% from the year-ago quarter.
The average prediction of analysts places 'Revenues- PCS' at $863.16 million. The estimate suggests a change of +4.4% year over year.
Over the past month, GE HealthCare shares have recorded returns of +3.4% versus the Zacks S&P 500 composite's +2.1% change. Based on its Zacks Rank #4 (Sell), GEHC will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q4 Earnings
Wall Street analysts expect GE HealthCare Technologies (GEHC - Free Report) to post quarterly earnings of $1.26 per share in its upcoming report, which indicates a year-over-year increase of 6.8%. Revenues are expected to be $5.33 billion, up 2.4% from the year-ago quarter.
The current level reflects a downward revision of 0.6% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
That said, let's delve into the average estimates of some GE HealthCare metrics that Wall Street analysts commonly model and monitor.
The consensus estimate for 'Revenues- Imaging' stands at $2.42 billion. The estimate suggests a change of -14.5% year over year.
According to the collective judgment of analysts, 'Revenues- Ultrasound' should come in at $1.41 billion. The estimate suggests a change of +49.4% year over year.
It is projected by analysts that the 'Revenues- Other' will reach $11.24 million. The estimate points to a change of -19.7% from the year-ago quarter.
The consensus among analysts is that 'Revenues- PDx' will reach $631.89 million. The estimate points to a change of +6.9% from the year-ago quarter.
The average prediction of analysts places 'Revenues- PCS' at $863.16 million. The estimate suggests a change of +4.4% year over year.
View all Key Company Metrics for GE HealthCare here>>>
Over the past month, GE HealthCare shares have recorded returns of +3.4% versus the Zacks S&P 500 composite's +2.1% change. Based on its Zacks Rank #4 (Sell), GEHC will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>